Skip to main content
SpringerLink
Log in

A case of donor cell leukemia driven by a de novo NRAS mutation with complex karyotype

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data Availability

Data is available upon request.

References

  1. Wiseman DH (2011) Donor cell leukemia: a review. Biol Blood Marrow Transplant 17(6):771–789. https://doi.org/10.1016/j.bbmt.2010.10.010

    Article  PubMed  Google Scholar 

  2. Galera P, Hsu AP, Wang W, Droll S, Chen R, Schwartz JR, Klco JM, Arai S, Maese L, Zerbe C, Parta MJ, Young NS, Holland SM, Hickstein DD, Calvo KR (2018) Donor-derived MDS/AML in families with germline GATA2 mutation. Blood 132(18):1994–1998. https://doi.org/10.1182/blood-2018-07-861070

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Xiao H, Shi J, Luo Y, Tan Y, He J, Xie W, Zhang L, Wang Y, Liu L, Wu K, Yu X, Cai Z, Lin M, Ye X, Huang H (2011) First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood 117(19):5257–5260. https://doi.org/10.1182/blood-2010-12-326322

    Article  CAS  PubMed  Google Scholar 

  4. Yasuda T, Ueno T, Fukumura K, Yamato A, Ando M, Yamaguchi H, Soda M, Kawazu M, Sai E, Yamashita Y, Murata M, Kiyoi H, Naoe T, Mano H (2014) Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation. Leukemia 28(2):426–428. https://doi.org/10.1038/leu.2013.278

    Article  CAS  PubMed  Google Scholar 

  5. Kobayashi S, Kobayashi A, Osawa Y, Nagao S, Takano K, Okada Y, Tachi N, Teramoto M, Kawamura T, Horiuchi T, Kato S, Maekawa T, Yamamura T, Watanabe J, Harada Y, Harada H, Sato K, Kimura F (2017) Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation. Leukemia 31(4):1020–1022. https://doi.org/10.1038/leu.2017.44

    Article  CAS  PubMed  Google Scholar 

  6. Assi R, Mahfouz R, Owen R, Gunthorpe M, Chehab FF, Bazarbachi A (2019) PAX5, NOTCH3, CBFB, and ACD drive an activated RAS pathway and monosomy 7 to B-ALL and AML in donor cell leukemia. Bone Marrow Transplant 54(7):1124–1128. https://doi.org/10.1038/s41409-018-0419-7

    Article  PubMed  Google Scholar 

  7. Zhou D, Xie T, Chen S, Ling Y, Xu Y, Chen B, Ouyang J, Yang Y (2020) An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report. BMC Cancer 20(1):195. https://doi.org/10.1186/s12885-020-6681-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Suárez-González J, Martínez-Laperche C, Kwon M, Balsalobre P, Carbonell D, Chicano M, Rodríguez-Macías G, Serrano D, Gayoso J, Díez-Martín JL, Buño I (2018) Donor cell-derived hematologic neoplasms after hematopoietic stem cell transplantation: a systematic review. Biol Blood Marrow Transplant 24(7):1505–1513. https://doi.org/10.1016/j.bbmt.2018.01.033

    Article  PubMed  Google Scholar 

  9. Simanshu DK, Nissley DV, McCormick F (2017) RAS proteins and their regulators in human disease. Cell 170(1):17–33. https://doi.org/10.1016/j.cell.2017.06.009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89(6):2079–2088

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by the National Research Foundation of Korea (NRF) grant (2021R1A2C1006302) funded by the Korea Government (MSIT).

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea

    Dajeong Jeong, Myoung-Seock Seo, Jee-Soo Lee, Yoon Hwan Chang, Moon-Woo Seong & Hyun Kyung Kim

  2. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

    Ja-Yoon Gu & Hyun Kyung Kim

  3. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea

    Sung-Soo Yoon

Authors
  1. Dajeong Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ja-Yoon Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Myoung-Seock Seo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jee-Soo Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoon Hwan Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Moon-Woo Seong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sung-Soo Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hyun Kyung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

H. K. K. designed the study. J-Y. G. and M-S. S. performed the experiments. J-S. L., Y. H. C., M-W. S., and S–S. Y. aided in implementation of the research. D. J. analyzed the data and wrote the manuscript.

Corresponding author

Correspondence to Hyun Kyung Kim.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the institutional review board of Seoul National University Hospital and requirement for informed consent was waived.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 23 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jeong, D., Gu, JY., Seo, MS. et al. A case of donor cell leukemia driven by a de novo NRAS mutation with complex karyotype. Ann Hematol 102, 1951–1952 (2023). https://doi.org/10.1007/s00277-023-05291-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05291-6

Search

Navigation